SCHEMBL19346015

SCHEMBL19346015

CC(CC(=O)O)NC(=O)NS(=O)(=O)c1ccc(N)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
GAA P10253 1/20 0.54
DHFR P00374 1/20 0.53
TSHR P16473 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
FBP1 P09467 1/20 0.51
MEN1 O00255 1/20 0.48
LMNA P02545 1/20 0.48
KMT2A Q03164 1/20 0.48
MMP1 P03956 2/20 0.46
MMP2 P08253 2/20 0.46
MMP9 P14780 2/20 0.46
MMP13 P45452 2/20 0.46
MMP3 P08254 1/20 0.46
MMP7 P09237 1/20 0.46
CA1 P00915 4/20 0.44
CA2 P00918 4/20 0.44
CA12 O43570 3/20 0.44
CA9 Q16790 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19332211 0.82 ALDH1A1 (0.66) ALDH1A1GAADHFRTSHRSMN1; SMN2
SCHEMBL19332656 0.78 ALDH1A1 (0.49) ALDH1A1GAADHFRTSHRSMN1; SMN2
SCHEMBL19346086 0.74 GAA (0.67) ALDH1A1GAATSHRTDP1LMNA
SCHEMBL19346083 0.74 GAA (0.60) ALDH1A1GAATSHRTDP1LMNA
SCHEMBL19332621 0.74 DHFR (0.68) ALDH1A1DHFRTSHRSMN1; SMN2TDP1
SCHEMBL14478907 0.73 FBP1 (0.68) ALDH1A1DHFRTSHRSMN1; SMN2TDP1
SCHEMBL23467914 0.72 GAA (0.69) ALDH1A1GAATSHRTDP1LMNA
SCHEMBL9237237 0.72 ALDH1A1 (1.00) ALDH1A1DHFRTSHRSMN1; SMN2TDP1
SCHEMBL15650208 0.72 ALDH1A1 (0.69) ALDH1A1GAADHFRTSHRSMN1; SMN2
SCHEMBL19332345 0.72 NPC1 (0.41) ALDH1A1SMN1; SMN2TDP1MMP2ADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017156181-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-09-14 WO disclosed